Revance Therapeutics | Penjualan

Sales Perubahan Tanggal
AbbVie USD 14.3B 374M 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Cara Therapeutics USD 3M 1.86M 2023-12
Coherus Biosciences USD 91.52M 16.96M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Endo International USD 497.73M 46.07M 2023-12
J&J USD 21.38B 15M 2024-03
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
P&G USD 21.44B 430M 2023-12
Pacira USD 181.24M 17.32M 2023-12
Revance Therapeutics USD 69.8M 13.02M 2023-12
Supernus Pharmaceuticals USD 164.31M 10.43M 2023-12



Revance Therapeutics Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.